Approval · Notice of Compliance 4831 · 2004

SENSIPAR: Notice of Compliance 4831

Issued August 9, 2004

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 4831
Date: August 9, 2004
Company: Amgen Canada IncMississauga, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Priority-NAS
Therapeutic class: Calcimimetic agent

Products in this notice

Brand	DIN	Status today
SENSIPAR	02257130	Cancelled Post Market
SENSIPAR	02257149	Cancelled Post Market
SENSIPAR	02257157	Cancelled Post Market

Medicinal ingredients

CINACALCET HYDROCHLORIDE 30 MG per TAB
CINACALCET HYDROCHLORIDE 60 MG per TAB
CINACALCET HYDROCHLORIDE 90 MG per TAB